Last Patient Out (LPO) from the Phase II study of linaprazan glurate
On September 1st, we had LPO – Last Patient Out, from the Phase II study of linaprazan glurate. The study includes a total of 228 patients.
Read moreCheck out the latest news from Cinclus Pharma
On September 1st, we had LPO – Last Patient Out, from the Phase II study of linaprazan glurate. The study includes a total of 228 patients.
Read moreGösta has extensive experience in leadership positions that will come in handy as Cinclus now prepares for the next step.
Read morePeter Unge's knowledge and long experience are essential assets in the clinical operations of Cinclus Pharma.
Read more